Palisade Bio (FRA:7NS0) FCF Yield % : -252.09 (As of Jun. 09, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Palisade Bio's Trailing 12-Month Free Cash Flow is €-9.97 Mil, and Market Cap is €3.93 Mil. Therefore, Palisade Bio's FCF Yield % for today is -252.09%.

The historical rank and industry rank for Palisade Bio's FCF Yield % or its related term are showing as below:

FRA:7NS0' s FCF Yield % Range Over the Past 10 Years
Min: -437.25 Med: -265.99 Max: -83.57
Current: -252.09

During the past 4 years, the highest FCF Yield % of Palisade Bio was -83.57%. The lowest was -437.25%. And the median was -265.99%.

FRA:7NS0's FCF Yield % is ranked worse than
93.44% of 1554 companies
in the Biotechnology industry
Industry Median: -13.915 vs FRA:7NS0: -252.09

Palisade Bio's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

Palisade Bio FCF Yield % Historical Data

The historical data trend for Palisade Bio's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio FCF Yield % Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

FCF Yield %

-74.67

-139.17

-190.26

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial											-93.71	-81.99	-208.29	-187.64	-273.60

Competitive Comparison of Palisade Bio's FCF Yield %

For the Biotechnology subindustry, Palisade Bio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palisade Bio's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palisade Bio's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Palisade Bio's FCF Yield % falls into.

Palisade Bio FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Palisade Bio's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-10.213	/	5.3678511
	=	-190.26%

Palisade Bio's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-2.926	*	4	/	4.2777825
	=	-273.60%

Palisade Bio FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Palisade Bio FCF Yield % Related Terms

Thank you for viewing the detailed overview of Palisade Bio's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (FRA:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (FRA:7NS0) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

PALI:USA

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (FRA:7NS0) Headlines

No Headlines